Thailand’s Sirikit Heart Center Awards Atorvastatin Procurement Contract Worth THB 5.29 Million

Introduction

Thailand has announced a new healthcare procurement contract as the Sirikit Heart Center of the Northeastern Region, Faculty of Medicine, confirmed the winning bidder for the supply of Atorvastatin 40 mg. The contract award highlights continued government investment in essential cardiovascular medicines and hospital pharmaceutical procurement.

Contract Details

The announcement, published on 30 January 2026, confirms the successful completion of a general procurement process for the purchase of Atorvastatin 40 mg.

Key procurement details:

• Project number - 69744108

• Procurement type - Purchase of pharmaceuticals

• Budget allocation - THB 11,500,000

• Winning bid value -THB 5,290,000

• Fiscal year - 2569 (Thailand fiscal calendar)

The procurement aims to ensure a stable supply of cholesterol-lowering medication for patients receiving treatment at the Sirikit Heart Center.

Winning Bidder

The contract has been awarded to T.O. Chemicals (1979) Co., Ltd., which submitted the successful bid of THB 5.29 million, significantly below the allocated budget.

The competitive bid demonstrates value-for-money procurement and cost savings for the public healthcare system.

Importance for Thailand’s Healthcare Sector

Supporting Cardiovascular Care

Atorvastatin is widely used to manage cholesterol levels and reduce the risk of heart disease and stroke. The procurement ensures uninterrupted access to critical medication for cardiac patients.

Cost Efficiency in Government Contracts

The winning bid came in well below the project budget, highlighting efficient public procurement and responsible healthcare spending.

Strengthening Hospital Pharmaceutical Supply

Reliable drug procurement plays a vital role in maintaining treatment continuity and improving patient outcomes in public hospitals.

Strategic Context

Thailand continues to strengthen public health infrastructure through transparent procurement and strategic purchasing of essential medicines. Ensuring consistent access to cardiovascular drugs is a key component of national health policy and preventive care programs.

Conclusion

The award of the Atorvastatin procurement contract marks another step in strengthening Thailand’s healthcare supply chain. With the contract now confirmed, the Sirikit Heart Center will move forward with supply and distribution to support patient treatment in the coming fiscal year.

#ThailandHealthcare #ContractAward #ProcurementNews #GovernmentContracts #PharmaceuticalProcurement #HospitalSupply #Atorvastatin #PublicHealth #MedicalSupplies